Company Filing History:
Years Active: 2016-2020
Title: Ling-Chu Chang: Innovator in Anticancer Research
Introduction
Ling-Chu Chang is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of anticancer research, holding a total of 3 patents. His work focuses on developing novel compounds that show promise in treating various types of cancer.
Latest Patents
One of his latest patents involves derivatives of curcuminoids and their use as anticancer agents. This series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids has demonstrated anticancer activity, particularly against breast cancer, colon cancer, and prostate cancer. Another notable patent relates to novel 20-sulfonylamidine derivatives of camptothecin, which includes methods of synthesizing these compounds and their application as antitumor agents for treating nasopharyngeal, lung, breast, or prostate cancer.
Career Highlights
Ling-Chu Chang has worked with esteemed institutions such as China Medical University and China Medical University Hospital. His research has significantly advanced the understanding and treatment of cancer through innovative chemical compounds.
Collaborations
He has collaborated with notable colleagues, including Sheng-Chu Kuo and Min-Tsang Hsieh, contributing to a rich environment of research and development in the field of oncology.
Conclusion
Ling-Chu Chang's innovative work in anticancer research highlights his commitment to improving cancer treatment options. His patents reflect a dedication to scientific advancement and the potential to save lives through effective therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.